Literature DB >> 25287479

Laboratory monitoring for pharmaceuticals: familiarity does not breed contempt.

Cynthia A Jackevicius1, Peter Glassman.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25287479      PMCID： PMC4242888          DOI： 10.1007/s11606-014-3048-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  9 in total

1.  Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients.

Authors:  Marsha A Raebel; Elizabeth A Chester; Elizabeth E Newsom; Ella E Lyons; Julia A Kelleher; Charron Long; Chad Miller; David J Magid
Journal:  Pharmacotherapy       Date:  2006-05       Impact factor: 4.705

2.  Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation.

Authors:  Aaron S Kesselheim; Kathrin Cresswell; Shobha Phansalkar; David W Bates; Aziz Sheikh
Journal:  Health Aff (Millwood)       Date:  2011-12       Impact factor: 6.301

3.  Thinking outside the (black) box: a new research agenda.

Authors:  Paul J Seligman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-06       Impact factor: 2.890

4.  Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty.

Authors:  V S Srinivas; Susan M Hailpern; Elana Koss; E Scott Monrad; Michael H Alderman
Journal:  J Am Coll Cardiol       Date:  2009-02-17       Impact factor: 24.094

5.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

6.  Provider and pharmacist responses to warfarin drug-drug interaction alerts: a study of healthcare downstream of CPOE alerts.

Authors:  Allison M Miller; Maureen S Boro; Nancy E Korman; J Ben Davoren
Journal:  J Am Med Inform Assoc       Date:  2011-10-28       Impact factor: 4.497

7.  Laboratory monitoring of drugs at initiation of therapy in ambulatory care.

Authors:  Marsha A Raebel; Ella E Lyons; Susan E Andrade; K Arnold Chan; Elizabeth A Chester; Robert L Davis; Jennifer L Ellis; Adrianne Feldstein; Margaret J Gunter; Jennifer Elston Lafata; Charron L Long; David J Magid; Joseph V Selby; Steven R Simon; Richard Platt
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

8.  Improving recognition of drug interactions: benefits and barriers to using automated drug alerts.

Authors:  Peter A Glassman; Barbara Simon; Pamela Belperio; Andrew Lanto
Journal:  Med Care       Date:  2002-12       Impact factor: 2.983

9.  Factors associated with ordering laboratory monitoring of high-risk medications.

Authors:  Shira H Fischer; Jennifer Tjia; George Reed; Daniel Peterson; Jerry H Gurwitz; Terry S Field
Journal:  J Gen Intern Med       Date:  2014-06-26       Impact factor: 5.128
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.